News
Issued by Pierre Fabre Pharmaceuticals, not Atara Biotherapeutics, Inc.
Perre Fabre Pharmaceuticals, Inc. Announces Transfer of Investigational New Drug Application for Tabelecleucel from Atara Biotherapeutics, Inc.
July 15, 2025 · View original source (PR Newswire)
It isn’t one of Atara Biotherapeutics, Inc.’s news releases, so 6ix doesn’t show it on Atara Biotherapeutics, Inc.’s page or send it as an alert.